All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Chugai Pharmaceutical Co., Ltd. revenue reports

Chugai Pharmaceutical Co., Ltd. financial reports, Chugai Pharmaceutical Co., Ltd. annual revenue in 2024. When does Chugai Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets

Chugai Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in US dollar today

Chugai Pharmaceutical Co., Ltd. current income in US dollar. The dynamics of Chugai Pharmaceutical Co., Ltd. net revenue grew by 52 594 000 000 $ compared to the previous report. The dynamics of net income of Chugai Pharmaceutical Co., Ltd. has changed by 23 315 000 000 $ in recent years. Chugai Pharmaceutical Co., Ltd. online financial report chart. The financial schedule of Chugai Pharmaceutical Co., Ltd. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of "net income" Chugai Pharmaceutical Co., Ltd. on the graph is displayed in blue.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 221 411 000 000 $ +33.38 % ↑ 70 726 000 000 $ +106.66 % ↑
31/03/2021 168 817 000 000 $ +9.42 % ↑ 47 411 000 000 $ +35.34 % ↑
31/12/2020 210 426 000 000 $ +18.66 % ↑ 52 308 000 000 $ +30.23 % ↑
30/09/2020 208 400 000 000 $ +10.52 % ↑ 60 133 000 000 $ +24.91 % ↑
31/12/2019 177 333 000 000 $ - 40 165 000 000 $ -
30/09/2019 188 566 000 000 $ - 48 141 000 000 $ -
30/06/2019 165 997 000 000 $ - 34 224 000 000 $ -
31/03/2019 154 288 000 000 $ - 35 031 000 000 $ -
Show:
to

Chugai Pharmaceutical Co., Ltd. financial report charts

The latest dates of Chugai Pharmaceutical Co., Ltd. financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Chugai Pharmaceutical Co., Ltd. for today is 30/06/2021. Gross profit Chugai Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Chugai Pharmaceutical Co., Ltd. is 153 352 000 000 $

Chugai Pharmaceutical Co., Ltd. quarterly report dates

Cost of revenue Chugai Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Chugai Pharmaceutical Co., Ltd. is 68 059 000 000 $ Total revenue Chugai Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Chugai Pharmaceutical Co., Ltd. is 221 411 000 000 $ Operating income Chugai Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Chugai Pharmaceutical Co., Ltd. is 96 712 000 000 $

Net income Chugai Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Chugai Pharmaceutical Co., Ltd. is 70 726 000 000 $ Current assets Chugai Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Chugai Pharmaceutical Co., Ltd. is 857 123 000 000 $ Total assets Chugai Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Chugai Pharmaceutical Co., Ltd. is 1 275 767 000 000 $

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
153 352 000 000 $ 113 479 000 000 $ 138 161 000 000 $ 139 042 000 000 $ 113 263 000 000 $ 114 546 000 000 $ 101 925 000 000 $ 90 380 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
68 059 000 000 $ 55 338 000 000 $ 72 265 000 000 $ 69 358 000 000 $ 64 070 000 000 $ 74 020 000 000 $ 64 072 000 000 $ 63 908 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
221 411 000 000 $ 168 817 000 000 $ 210 426 000 000 $ 208 400 000 000 $ 177 333 000 000 $ 188 566 000 000 $ 165 997 000 000 $ 154 288 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
96 712 000 000 $ 63 966 000 000 $ 73 912 000 000 $ 86 690 000 000 $ 49 719 000 000 $ 65 826 000 000 $ 48 959 000 000 $ 46 094 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
70 726 000 000 $ 47 411 000 000 $ 52 308 000 000 $ 60 133 000 000 $ 40 165 000 000 $ 48 141 000 000 $ 34 224 000 000 $ 35 031 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
33 562 000 000 $ 29 727 000 000 $ 32 832 000 000 $ 30 143 000 000 $ 31 031 000 000 $ 25 089 000 000 $ 26 683 000 000 $ 25 139 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
124 699 000 000 $ 104 851 000 000 $ 136 514 000 000 $ 121 710 000 000 $ 127 614 000 000 $ 122 740 000 000 $ 117 038 000 000 $ 108 194 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
857 123 000 000 $ 740 971 000 000 $ 834 906 000 000 $ 742 331 000 000 $ 699 680 000 000 $ 668 039 000 000 $ 634 246 000 000 $ 598 889 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 275 767 000 000 $ 1 144 627 000 000 $ 1 235 498 000 000 $ 1 136 108 000 000 $ 1 058 915 000 000 $ 1 025 336 000 000 $ 986 620 000 000 $ 932 242 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
187 131 000 000 $ 162 049 000 000 $ 212 333 000 000 $ 182 711 000 000 $ 203 941 000 000 $ 177 022 000 000 $ 149 165 000 000 $ 125 818 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 179 268 000 000 $ 178 271 000 000 $ 159 588 000 000 $ 136 523 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 204 930 000 000 $ 212 200 000 000 $ 194 455 000 000 $ 171 778 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 19.35 % 20.70 % 19.71 % 18.43 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 052 058 000 000 $ 982 608 000 000 $ 980 003 000 000 $ 925 270 000 000 $ 853 985 000 000 $ 813 136 000 000 $ 792 165 000 000 $ 760 464 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 78 608 000 000 $ 62 737 000 000 $ 32 256 000 000 $ 33 040 000 000 $

Last revenue report of Chugai Pharmaceutical Co., Ltd. was 30/06/2021. According to last financial report total revenue in Chugai Pharmaceutical Co., Ltd. was 221 411 000 000 US dollar and changed by +33.38% since last year. Net income in Chugai Pharmaceutical Co., Ltd. was 70 726 000 000 $ in last quartal, net income changes to +106.66%.

Current cash Chugai Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Chugai Pharmaceutical Co., Ltd. is 187 131 000 000 $

Chugai Pharmaceutical Co., Ltd. stocks data

Chugai Pharmaceutical Co., Ltd. financials